kyc_gsk
DESCRIPTION
know your company gskTRANSCRIPT
A B-Gyan Initiative 1
London, United Kingdom. It is the world's fourth-largest pharmaceutical
company measured by prescription drug sales (after Pfizer, Novartis, and
Sanofi).
It was established in 2000 by the merger of Glaxo Wellcome plc (formed from
the acquisition of Wellcome plc by Glaxo plc) and SmithKline Beecham plc
laxoSmithKline plc. (GSK) is a British multinational pharmaceutical, biologics,
vaccines and consumer healthcare company headquartered in London, United
Kingdom. GSK Consumer Healthcare is a dominant player in nutritional
healthcare, oral healthcare and OTC medication.
GSK is one of the few healthcare companies researching both medicines and
vaccines for the World Health Organization’s three priority diseases –
HIV/AIDS, tuberculosis and malaria.
The Company produces medicines that treat major disease areas such as
asthma, anti-virals, infections, mental health, diabetes, cardiovascular and
digestive conditions. In addition, GSK is a leader in the important area of
vaccines and is developing new treatments for cancer.
COMPANY INFORMATION
• GSK Consumer Healthcare (GSKCH)
A B-Gyan Initiative 2
Founded 2000 – Founded partnership
Leadership Chris Gent (Chairman)
Andrew Witty (Chief Executive)
Stock Listing: Primary - London Stock Exchange
Secondary – New York Stock Exchange
FINANCIAL STATISTICS (FY 2012 – 13)
PRODUCTS CATEGORIES
Prescription medicines
The prescription medicines include treatments for a wide range of
conditions such as infections, depression, skin conditions, asthma, heart
and circulatory disease and cancer.
Vaccines
A B-Gyan Initiative 3
typhoid, influenza and bacterial meningitis.
Consumer Healthcare
GSK brings dental health products, over-the-counter medicines and
nutritional drinks to millions of people. Many of their brands, such as
Sensodyne, Panadol, Aquafresh, Lucozade and Nicorette/Niquitin are
familiar around the world.
Star Products in OTC category: ENO, Crocin and Iodex
PRODUCTS MARKETED BY GSK
• smoking control products Nicorette/Niquitin
SALIENT FEATURES
GSK worldwide
Employ over 97,000 people in over 100 countries
Around 12,500 people work in our research teams across the world to
discover new medicines
worldwide
Every second, GSK distributes more than 35 doses of Vaccines.
Every minute, more than 1100 prescriptions are written for GSK
products.
Every hour GSK spend more than £ 300,000 (US$562,000) to find new
medicines
GSK India
In India, GSK is one of the market leaders with a turnover of Rs. 2699
crore and a share of 4.2 percent
A B-Gyan Initiative 4
helminthic, hormones
GSK has 5 products in the top 50 brands, and the top five GSK products
are Augmentin, Calpol, Zinetac, Betnesol and Ceftum
GSK's vaccines division is ranked second in a fast-growing vaccines
market. Some leading products in India are Varilrix, Havrix, Rotarix,
Cervarix and Engerix B
GSK India's R&D centers at Thane and Nashik have been granted
recognition by the Department of Scientific and Industrial Research,
Government of India.
SUPPLY CHAIN STRATEGY
GlaxoSmithKline is targeting improvements in its supply chain in the next
stage of its strategy to reduce its cost base, the company showing operating
profits up 42% to £3.8 billion, on sales 7.5% lower at £13.3 billion.
It its interim report GSK noted that: “Working capital increased by £380 million
in the half-year, largely as a result of increased inventory holdings for seasonal
and new product stock-building. Consequently, working capital conversion
declined by 15 days compared with 31st December 2012.”
The pharma giant is nearing the end of its current operational excellence
programme,which has focused on issues such as improving the selling model,
streamlining global manufacturing, enhancing research and development
efficiency, and reducing bureaucracy.
Product
Place
1800 wholesalers and direct coverage of over 4,00,000 retail outlets
South and Eastern markets which contributes about 46 per cent and 47 per
cent of the total sales
Price
A B-Gyan Initiative 5
for kids (6-16) and mothers,
The brand also takes the medical platform by labeling the product as "Clinically
Proven ".
Healthcare's flagship Horlicks milk drink, is now the consumergoods
company's fastest growing product with sales topping Rs 100 crore in
2013.
2. GlaxoSmithKline Consumer Healthcare Ltd, the maker of Horlicks and
Boost health food drinks, is looking at setting up a large manufacturing
facility close to the east coast in southern Andhra Pradesh.
3. GSK is scouting for about 100 acres of land at the two locations, apart
from connectivity to the natural gas grid, and has conveyed plans to
produce Foodles, which is its instant noodles product, biscuits and oats
under the Horlicks brand, apart from health food drinks.
London, United Kingdom. It is the world's fourth-largest pharmaceutical
company measured by prescription drug sales (after Pfizer, Novartis, and
Sanofi).
It was established in 2000 by the merger of Glaxo Wellcome plc (formed from
the acquisition of Wellcome plc by Glaxo plc) and SmithKline Beecham plc
laxoSmithKline plc. (GSK) is a British multinational pharmaceutical, biologics,
vaccines and consumer healthcare company headquartered in London, United
Kingdom. GSK Consumer Healthcare is a dominant player in nutritional
healthcare, oral healthcare and OTC medication.
GSK is one of the few healthcare companies researching both medicines and
vaccines for the World Health Organization’s three priority diseases –
HIV/AIDS, tuberculosis and malaria.
The Company produces medicines that treat major disease areas such as
asthma, anti-virals, infections, mental health, diabetes, cardiovascular and
digestive conditions. In addition, GSK is a leader in the important area of
vaccines and is developing new treatments for cancer.
COMPANY INFORMATION
• GSK Consumer Healthcare (GSKCH)
A B-Gyan Initiative 2
Founded 2000 – Founded partnership
Leadership Chris Gent (Chairman)
Andrew Witty (Chief Executive)
Stock Listing: Primary - London Stock Exchange
Secondary – New York Stock Exchange
FINANCIAL STATISTICS (FY 2012 – 13)
PRODUCTS CATEGORIES
Prescription medicines
The prescription medicines include treatments for a wide range of
conditions such as infections, depression, skin conditions, asthma, heart
and circulatory disease and cancer.
Vaccines
A B-Gyan Initiative 3
typhoid, influenza and bacterial meningitis.
Consumer Healthcare
GSK brings dental health products, over-the-counter medicines and
nutritional drinks to millions of people. Many of their brands, such as
Sensodyne, Panadol, Aquafresh, Lucozade and Nicorette/Niquitin are
familiar around the world.
Star Products in OTC category: ENO, Crocin and Iodex
PRODUCTS MARKETED BY GSK
• smoking control products Nicorette/Niquitin
SALIENT FEATURES
GSK worldwide
Employ over 97,000 people in over 100 countries
Around 12,500 people work in our research teams across the world to
discover new medicines
worldwide
Every second, GSK distributes more than 35 doses of Vaccines.
Every minute, more than 1100 prescriptions are written for GSK
products.
Every hour GSK spend more than £ 300,000 (US$562,000) to find new
medicines
GSK India
In India, GSK is one of the market leaders with a turnover of Rs. 2699
crore and a share of 4.2 percent
A B-Gyan Initiative 4
helminthic, hormones
GSK has 5 products in the top 50 brands, and the top five GSK products
are Augmentin, Calpol, Zinetac, Betnesol and Ceftum
GSK's vaccines division is ranked second in a fast-growing vaccines
market. Some leading products in India are Varilrix, Havrix, Rotarix,
Cervarix and Engerix B
GSK India's R&D centers at Thane and Nashik have been granted
recognition by the Department of Scientific and Industrial Research,
Government of India.
SUPPLY CHAIN STRATEGY
GlaxoSmithKline is targeting improvements in its supply chain in the next
stage of its strategy to reduce its cost base, the company showing operating
profits up 42% to £3.8 billion, on sales 7.5% lower at £13.3 billion.
It its interim report GSK noted that: “Working capital increased by £380 million
in the half-year, largely as a result of increased inventory holdings for seasonal
and new product stock-building. Consequently, working capital conversion
declined by 15 days compared with 31st December 2012.”
The pharma giant is nearing the end of its current operational excellence
programme,which has focused on issues such as improving the selling model,
streamlining global manufacturing, enhancing research and development
efficiency, and reducing bureaucracy.
Product
Place
1800 wholesalers and direct coverage of over 4,00,000 retail outlets
South and Eastern markets which contributes about 46 per cent and 47 per
cent of the total sales
Price
A B-Gyan Initiative 5
for kids (6-16) and mothers,
The brand also takes the medical platform by labeling the product as "Clinically
Proven ".
Healthcare's flagship Horlicks milk drink, is now the consumergoods
company's fastest growing product with sales topping Rs 100 crore in
2013.
2. GlaxoSmithKline Consumer Healthcare Ltd, the maker of Horlicks and
Boost health food drinks, is looking at setting up a large manufacturing
facility close to the east coast in southern Andhra Pradesh.
3. GSK is scouting for about 100 acres of land at the two locations, apart
from connectivity to the natural gas grid, and has conveyed plans to
produce Foodles, which is its instant noodles product, biscuits and oats
under the Horlicks brand, apart from health food drinks.